✦ LIBER ✦

Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer

✍ Scribed by Walter H. Gotlieb; Angela Chetrit; Joseph Menczer; Galit Hirsh-Yechezkel; Flora Lubin; Eitan Friedman; Baruch Modan; Gilad Ben-Baruch

Book ID: 113959865
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 85 KB
Volume: 97
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2005.02.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Socioeconomic status and health insuranc

Socioeconomic status and health insurance as predictors of access to high-volume hospital care for women with early-stage ovarian cancer

✍ Liu, F.W.; Chang, J.; Hodeib, M.; Ziogas, A.; Penner, K.; Anton-Culver, H.; Bris 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Ovarian papillary serous tumors of low m

Ovarian papillary serous tumors of low malignant potential (Serous borderline tumors): A long term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma

✍ Alexander W. Kennedy; William R. Hart 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

## Background: The clinical outcome of patients with ovarian serous tumors of low malignant potential (lmp) remains controversial, especially for those with extraovarian disease. we retrospectively reviewed our experience to study this question further, to assess the safety of conservative manageme

Role of 18F-FDG PET/CT in diagnosing per

Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125

✍ Rubini, G.; Altini, C.; Notaristefano, A.; Merenda, N.; Rubini, D.; Ianora, A.A. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 771 KB

Significant differences of lymphocytes i

Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance

✍ A. Bamias; M.L. Tsiatas; E. Kafantari; C. Liakou; A. Rodolakis; Z. Voulgaris; G. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Nadir CA125 and second look surgery in p

Nadir CA125 and second look surgery in patients with advanced stage epithelial ovarian cancer treated with intravenous compared to intraperitoneal chemotherapy: A study of Gynecologic Oncology Group Protocols 114 and 172

✍ S. Richard; A. Miller; M. Markman; D. Armstrong; J. Walker; T. Krivak 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 128 KB

949 POSTER Antiangiogenesis as new treat

949 POSTER Antiangiogenesis as new treatment modality in ovarian cancer: a phase Ib, open label, safety and pharmacokinetics (PK) study of escalating doses of PTK787/ZK222584 (PTK/ZK) in combination with paclitaxel and carboplatin in patients (pts) with stage IC to IV epithelial ovarian cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB